320 related articles for article (PubMed ID: 20608988)
1. Gender and the renin-angiotensin-aldosterone system.
Komukai K; Mochizuki S; Yoshimura M
Fundam Clin Pharmacol; 2010 Dec; 24(6):687-98. PubMed ID: 20608988
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system].
Maksimov ML
Ter Arkh; 2010; 82(6):77-80, inside back cover. PubMed ID: 20731118
[TBL] [Abstract][Full Text] [Related]
4. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
Weinberg MS; Weinberg AJ; Zappe DH
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
[No Abstract] [Full Text] [Related]
5. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
6. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Weir MR; Rolfe M
Clin J Am Soc Nephrol; 2010 Mar; 5(3):531-48. PubMed ID: 20150448
[TBL] [Abstract][Full Text] [Related]
7. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
Gensini GF; Lippi D; Conti AA
Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
[TBL] [Abstract][Full Text] [Related]
8. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
9. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
Horký K
Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
12. To live alone and to be depressed, an alarming combination for the renin-angiotensin-aldosterone-system (RAAS).
Häfner S; Baumert J; Emeny RT; Lacruz ME; Bidlingmaier M; Reincke M; Kuenzel H; Holle R; Rupprecht R; Ladwig KH;
Psychoneuroendocrinology; 2012 Feb; 37(2):230-7. PubMed ID: 21742440
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the cardiovascular effects of sex hormones.
Vitale C; Fini M; Speziale G; Chierchia S
Fundam Clin Pharmacol; 2010 Dec; 24(6):675-85. PubMed ID: 20199585
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
Re RN
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
[TBL] [Abstract][Full Text] [Related]
15. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
16. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease.
Sandberg K; Ji H
Adv Ren Replace Ther; 2003 Jan; 10(1):15-23. PubMed ID: 12616459
[TBL] [Abstract][Full Text] [Related]
17. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
Turgut F; Balogun RA; Abdel-Rahman EM
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
[TBL] [Abstract][Full Text] [Related]
19. Hypertension in women: the role of progesterone and aldosterone.
Boschitsch E; Mayerhofer S; Magometschnigg D
Climacteric; 2010 Aug; 13(4):307-13. PubMed ID: 20443718
[TBL] [Abstract][Full Text] [Related]
20. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
